Walgreens Boots Alliance said Wednesday its $17.2 billion takeover of Rite Aid would not diminish competition because of the growing importance of mail-order sales and other rivals to retail pharmacies.
Walgreens Boots chief executive Stefano Pessina highlighted this type of competition in remarks that appeared to foreshadow the company’s potential arguments to US antitrust regulators. Big-box chains like Wal-Mart and supermarkets have become big players in selling prescription drugs.
“Think of the mail-order, think of the people in specialized,” Pessina said in an earnings conference call.
“We are in an environment where there is a lot of competition,” Pessina said. “And the fact that we put together two companies will not reduce the competition.”
The merger, announced after markets closed Tuesday, would create a strong rival to market leader CVS Health, combining Walgreens Boots’s 13,100 stores in a dozen countries with Rite Aid’s 4,600 stores in the US.
Full content: KPBS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI